May 19 - 20, 2021 Presentation times and weblinks released for over 60 presenting companies
Sidoti & Company, LLC has released the presentation schedule and weblinks for its two-day spring Microcap Virtual Conference taking place Wednesday and Thursday, May 19 - 20, 2021. The links can also be found at www.sidoticonference.com/events.
Group Presentation Schedule (click on the company name to register & watch) | ||||
Wednesday, May 19th, 2021 (Day 1) | ||||
*All Times EDT | ||||
8:30-9:00 | **** | |||
9:15-9:45 | ||||
10:00-10:30 | ||||
10:45-11:15 | ||||
11:30-12:00 | **** | |||
12:15-12:45 | ||||
1:00-1:30 | ||||
1:45-2:15 | ||||
2:30-3:00 | ||||
3:15-3:45 | **** | |||
4:00-4:30 |
Thursday, May 20th, 2021 (Day 2) | ||||
*All Times EDT | ||||
8:30-9:00 | **** | |||
9:15-9:45 | **** | |||
10:00-10:30 | **** | |||
10:45-11:15 | ||||
11:30-12:00 | ||||
12:15-12:45 | ||||
1x1s Only - No Presentation | Blueknight (BKEP) || LSB Industries (LXU) |
About Sidoti
For over two decades, Sidoti has been a premier provider of independent securities research focused specifically on small and microcap companies and the institutions that invest their securities, with most of our coverage in the $50 million to $4 billion market cap range. Our approach affords companies and institutional clients a combination of high-quality research, a small and microcap focused nationwide sales effort, broad access to corporate management teams, and extensive trading support. We serve 500+ institutional clients in North America, including many leading managers of portfolios with $200 million to $2 billion of AUM. Sidoti promotes meaningful interaction between issuers and investors in the small and microcap space through our conferences (www.sidoticonference.com) and the hundreds of non-deal roadshows we host each year.
Contact
Sidoti Events Team
212-453-7031
This email address is being protected from spambots. You need JavaScript enabled to view it.
Last Trade: | C$4.47 |
Daily Change: | -0.28 -5.89 |
Daily Volume: | 307,447 |
Market Cap: | C$110.190M |
January 22, 2025 November 18, 2024 November 07, 2024 September 16, 2024 |
Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...
CLICK TO LEARN MORERecursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....
CLICK TO LEARN MOREEnd of content
No more pages to load